000 01504 a2200457 4500
005 20250517114922.0
264 0 _c20170815
008 201708s 0 0 eng d
022 _a1365-2036
024 7 _a10.1111/apt.13802
_2doi
040 _aNLM
_beng
_cNLM
100 1 _aSpradling, P R
245 0 0 _aDistribution of disease phase, treatment prescription and severe liver disease among 1598 patients with chronic hepatitis B in the Chronic Hepatitis Cohort Study, 2006-2013.
_h[electronic resource]
260 _bAlimentary pharmacology & therapeutics
_c11 2016
300 _a1080-1089 p.
_bdigital
500 _aPublication Type: Journal Article; Multicenter Study
650 0 4 _aAdolescent
650 0 4 _aAdult
650 0 4 _aCohort Studies
650 0 4 _aFemale
650 0 4 _aHepatitis B e Antigens
_xblood
650 0 4 _aHepatitis B, Chronic
_xblood
650 0 4 _aHumans
650 0 4 _aLiver Cirrhosis
_xblood
650 0 4 _aMale
650 0 4 _aMiddle Aged
650 0 4 _aUnited States
_xepidemiology
650 0 4 _aYoung Adult
700 1 _aXing, J
700 1 _aRupp, L B
700 1 _aMoorman, A C
700 1 _aGordon, S C
700 1 _aTeshale, E T
700 1 _aLu, M
700 1 _aBoscarino, J A
700 1 _aSchmidt, M A
700 1 _aTrinacty, C M
700 1 _aHolmberg, S D
773 0 _tAlimentary pharmacology & therapeutics
_gvol. 44
_gno. 10
_gp. 1080-1089
856 4 0 _uhttps://doi.org/10.1111/apt.13802
_zAvailable from publisher's website
999 _c26429617
_d26429617